Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    10921554 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Suspended Phase II Study To Evaluate The Safety and Efficacy of Hemoglobin Raffimer in Patients Undergoing First Time CABG Surgery
Condition: Cardiovascular Disease
Intervention: Drug: Hemolink (hemoglobin raffimer IV solution)

Indicates status has not been verified in more than two years